I’m not sure you understand what proof of concept means. The fact you mentioned phase 3 trials makes me question your understanding of medical devices. Actually I was never questioning it, it’s clear you don’t understand anything to do with this stock, or any in this field.
Ann: BTM delivers positive First in Man results in Cell Therapies, page-78
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.21 |
Change
0.025(2.11%) |
Mkt cap ! $837.6M | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.23 | $1.17 | $1.830M | 1.520M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1990 | $1.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 4524 | 1 |
View Market Depth
| Last trade - 15.59pm 24/06/2025 (20 minute delay) ? |
| PNV (ASX) Chart |